Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Pharmacol Rep ; 71(3): 517-521, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31009843

ABSTRACT

BACKGROUND: Cyclic neucleotides are involved in many cellular functions including smooth muscle relaxation, inflammation, and signal transduction. Sildenafil and tadalafil are phosphodiesterase-5 (PDE-5) inhibitors which prevent the degradation of cyclic neucleotide i.e. guanosine 3',5' cyclic monophosphate (cGMP) and increase the levels of cGMP. In this study sildenafil and tadalafil were evaluated for their anti-inflammatory, anti-oxidative and anti-nitrosative stress potential in animal model of bronchial asthma. METHODS: Wistar rats were sensitized with 10 mg intraperitoneal (ip) ovalbumin adsorbed to 10 µg of aluminum hydroxide on day 0. Animals were given sildenafil (1 and 3 mg/kg ip) and tadalafil (1 and 3 mg/kg ip) from day 1 to day 14. Also, on day 14 animals were challenged with ovalbumin (1 mg ip). After 24 h, samples were collected to analyze interleukin-4 (IL-4) and tumour necrosis factor-α (TNF-α), in serum and bronchoalveolar lavage fluid (BALF). The oxidative stress markers malondialdehyde (MDA), reduced glutathione (GSH) and nitric oxide metabolites (NOx) were also measured in serum. RESULTS: Pre-treatment with sildenafil (1 and 3 mg/kg ip) and tadalafil (1 and 3 mg/kg ip) significantly reduced the levels of pro-inflammatory cytokines IL-4 and TNF-α in rat serum and BALF. In addition, pre-treatment with both the drugs decreased the levels of MDA and NOx and increased the levels of GSH in serum. CONCLUSIONS: Sildenafil and tadalafil decreased pro-inflammatory cytokines in serum and BALF. Both drugs inhibit oxidative and nitrosative stress in animal model of bronchial asthma and could have a therapeutic potential in bronchial asthma.


Subject(s)
Asthma/drug therapy , Bronchi/drug effects , Inflammation/drug therapy , Nitrosative Stress/drug effects , Oxidative Stress/drug effects , Sildenafil Citrate/pharmacology , Tadalafil/pharmacology , Animals , Asthma/metabolism , Bronchi/metabolism , Bronchoalveolar Lavage Fluid/chemistry , Cytokines/metabolism , Disease Models, Animal , Female , Glutathione/metabolism , Inflammation/metabolism , Lung/drug effects , Lung/metabolism , Male , Malondialdehyde/metabolism , Nitric Oxide/metabolism , Rats , Rats, Wistar
2.
Environ Sci Pollut Res Int ; 26(10): 9632-9639, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30734250

ABSTRACT

The increased exposure to cadmium (Cd) through environmental pollutants, food and cigarette smoke is a concern worldwide. The association of Cd with impaired learning disabilities led us to hypothesise that cadmium levels in brain tissue could be dose-dependently related to the extent of memory impairment and oxidative stress. In this study, we proposed to study whether cadmium exposure to dams could alter the brain Cd levels, memory parameters, antioxidant enzymes in brain and their gene expression in the F1-F2 generation mice and whether quercetin could modulate this effect. Animals were administered Cd alone and in combination with quercetin for 7 days during their gestation period. Their newborn pups (F1 and F2 mice) were reared until adulthood and were tested for memory using Morris water maze and step-down latency test. The brain tissue of F1 mice was collected. Cd levels were estimated using the atomic absorption spectrophotometer. G-S-transferase (GST) and catalase (CAT) activity were measured and fold increase in their respective gene expression was observed using the RT-PCR method. Cd levels were significantly increased in the brain tissue of animals exposed to Cd but cotreatment with quercetin showed decreased levels in both generations. Memory impairment was observed in animals of F1 generation exposed to Cd and cotreatment with quercetin (100 mg/kg) reversed this effect. Cd exposure significantly enhanced both activity and expression of GST and CAT in the brain tissue of F1 generation mice and quercetin attenuated this effect. In F2 generation, results were variable. GST activity and expression increased with Cd and decreased with quercetin cotreatment. However, CAT activity showed no significant change despite a decrease in gene expression. Quercetin cotreatment enhanced activity as well gene expression in F2 generation. Our study insinuates that Cd levels could act as a predictor of memory impairment and altered enzyme activity and gene expression in brain tissue. Quercetin helped to reduce Cd levels in brain tissue of F1 and F2 generation and modulated the antioxidant system of the cell by affecting expression of antioxidant enzymes at the transcription level.


Subject(s)
Brain/metabolism , Cadmium/toxicity , Environmental Pollutants/toxicity , Memory/drug effects , Quercetin/metabolism , Animals , Antioxidants , Brain/drug effects , Cadmium/metabolism , Environmental Pollutants/metabolism , Female , Male , Memory Disorders , Mice , Oxidative Stress , Toxicity Tests
3.
Metab Brain Dis ; 33(6): 1935-1943, 2018 12.
Article in English | MEDLINE | ID: mdl-30069621

ABSTRACT

We investigated whether in-utero Cd(II) chloride exposure of the dams between 14th to 21st day of gestation affects memory and learning, oxidative stress, antioxidant enzyme activity and their gene expression in brain of the pups in their adulthood. In the Morris water maze, cadmium (Cd) exposure impaired spatial memory which was reversed following co-treatment with quercetin (100 mg/kg). In the passive avoidance paradigm, retention memory was adversely affected but was significantly reversed by co treatment with quercetin (25, 50, 100 mg/kg). The malondialdehyde and catalase (CAT) levels and glutathione-S-transferase (GST) activity were increased significantly in Cd-treated group, but were reversed by quercetin (all doses). The gene expression for CAT and GST in brain tissue of Cd treated animals also increased many folds as compared to the control, and this effect was decreased on co-treatment with quercetin (all doses), thus matching with the respective enzyme activities. Quercetin (25 mg/kg) when co-treated with Cd caused a decrease in GST activity compared to control, which points towards a complex interplay with oxidative free radicals and promoters and transcription factors. Thus, Cd exposure during late gestation causes impaired spatial and retention memory in the next generation which may be due to alteration of activity as well as gene expression of the antioxidant enzymes, CAT and GST. Quercetin may offer some protection of memory impairment probably by modulating these effects.


Subject(s)
Antioxidants/metabolism , Brain/drug effects , Cadmium/toxicity , Cognitive Dysfunction/drug therapy , Oxidative Stress/drug effects , Quercetin/therapeutic use , Animals , Avoidance Learning/drug effects , Avoidance Learning/physiology , Brain/metabolism , Cognitive Dysfunction/chemically induced , Cognitive Dysfunction/metabolism , Female , Gene Expression , Male , Mice , Oxidative Stress/physiology , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/drug therapy , Prenatal Exposure Delayed Effects/metabolism , Quercetin/pharmacology , Random Allocation
4.
Drug Chem Toxicol ; 39(3): 272-8, 2016.
Article in English | MEDLINE | ID: mdl-26446883

ABSTRACT

Cadmium (Cd) is a known pollutant present in the environment at low levels and is reported to affect reproduction in many ways. The present study was undertaken to explore the effect of Cd in F1 generation mice on cognitive parameters, and to further investigate whether quercetin could modulate these effects. In this study, female lactating mice were exposed to cadmium for seven days just after delivery. The new born pups in their adulthood were tested for learning and memory parameters by passive avoidance task and Morris water maze (MWM) test. It was observed that pups exposed to Cd showed significant impairment of memory in step down latency test, which was reversed by quercetin (100 mg/kg). In MWM test for spatial memory, animals exposed to Cd exhibited increased escape latency, which was reversed by quercetin (50 mg/kg) significantly. Quercetin alone (50 and 100 mg/kg) also demonstrated improved spatial memory, and showed improved retention memory in the passive avoidance paradigm at dose 50 mg/kg. On testing oxidative stress parameters, we observed significantly increased malondialdehyde (MDA) levels in brain tissue of Cd-treated mice. Moreover, co-treatment with quercetin (50 mg/kg) and Cd significantly reduced these MDA levels. The other doses (25 and 100 mg/kg) also showed reduction in MDA levels as compared to the group exposed to Cd alone, though the difference was not statistically significant. Hence, this study highlights the possibility of cognitive impairment in adulthood if there is Cd exposure during lactation and oxidative stress could possibly attribute to this effect.


Subject(s)
Antioxidants/pharmacology , Cadmium/toxicity , Environmental Pollutants/toxicity , Lactation , Maze Learning/drug effects , Memory/drug effects , Quercetin/pharmacology , Animals , Animals, Newborn , Avoidance Learning/drug effects , Brain/drug effects , Brain/growth & development , Brain/metabolism , Brain/physiopathology , Female , Male , Mice , Oxidative Stress/drug effects
5.
Biol Trace Elem Res ; 171(2): 391-398, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26521059

ABSTRACT

In the present study, we investigated whether chromium (Cr) administered to the dams (F0) during lactation period could affect memory and oxidative stress in F1 generation mice in their adulthood and whether quercetin could modulate these effects. Morris water maze (MWM) was used to test for spatial memory. Passive avoidance task and elevated plus maze were used to test for acquisition and retention memory. Oxidative stress was evaluated by measuring glutathione-S-transferase (GST), catalase activity and malonaldehyde (MDA) levels in the brain tissue. The results of MWM showed that the animals in the Cr-treated group compared to control have better spatial memory that was further enhanced when Cr was administered along with quercetin (50 mg/kg). The elevated plus maze test also showed the Cr-treated group to improve acquisition as well as retention memory compared to control. Co-treatment with quercetin (all doses) also exhibited enhanced acquisition and retention memory compared to control. The passive avoidance task demonstrated no significant improvement in memory in the Cr-treated mice but co-treatment with quercetin (100 mg/kg) showed improved acquisition memory compared to control which was significantly better than the animals treated with chromium alone. GST activity was significantly increased in the Cr-treated animals, and this was further increased in groups treated with Cr and quercetin (all doses). Chromium when administered alone and in combination with quercetin (all doses) significantly reduced MDA levels. However, Cr treatment did not show significant change in catalase activity. Nevertheless, co-treatment with quercetin (25 and 50 mg/kg) resulted in significant decrease in catalase activity. Thus, our study demonstrates that Cr exposure during lactation could be beneficial for pups with respect to augmentation of cognitive function and reduction of oxidative stress. Quercetin could probably enhance this effect to some extent.


Subject(s)
Antioxidants/metabolism , Catalase/metabolism , Chromium/pharmacology , Glutathione Transferase/metabolism , Maze Learning/drug effects , Memory/drug effects , Quercetin/pharmacology , Animals , Chromium/administration & dosage , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Female , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Mice , Oxidative Stress/drug effects
6.
Eur J Pharmacol ; 736: 95-100, 2014 Aug 05.
Article in English | MEDLINE | ID: mdl-24791680

ABSTRACT

Modafinil [2-((diphenylmethyl) sulfinyl) acetamide] is a central nervous system stimulant. It has received considerable attention as a potential psychotropic agent in several psychiatric disorders. The current study was carried out to investigate the effect of modafinil after acute administration on animal models of pain in mice. Also, this study evaluated the effect of L-NG-nitroarginine methyl ester (L-NAME), 7-nitroindazole (7-NI) and naloxone following chronic administration of modafinil. Modafinil was administered in the doses of 50, 100 or 200 mg/kg once in acute study and it showed significantly increased tail-flick latency (tfl) and paw-licking latency. In formalin test modafinil (100 mg/kg) significantly reduced licking/biting time in both early and late phases in comparison to control. In chronic study, modafinil 100 mg/kg administered for 10 days, produced a progressive decrease in the reaction time (i.e., tfl/paw-licking latency) in comparison to day 1 values which started building up from day 4 and fully established at day 6, indicating hyperalgesic response. Prior administration of 7-NI (on day 7) and L-NAME (on day 10) prevented the hyperalgesic response while naloxone on day 10 did not have a significant effect on modafinil-induced hyperalgesia. These results demonstrate that modafinil has a potential role in pain as it exhibited antinociceptive effect after acute administration in a dose-dependent manner and on chronic administration it caused hyperalgesia. This hyperalgesia is reversed by nitric oxide synthase inhibitors, suggesting the possibility of involvement of nitric oxide pathway. Further studies are required to evaluate the role of modafinil in clinical pain.


Subject(s)
Analgesics , Benzhydryl Compounds , Central Nervous System Stimulants , Hyperalgesia/chemically induced , Pain/drug therapy , Analgesics/adverse effects , Analgesics/therapeutic use , Animals , Behavior, Animal/drug effects , Benzhydryl Compounds/adverse effects , Benzhydryl Compounds/therapeutic use , Central Nervous System Stimulants/adverse effects , Central Nervous System Stimulants/therapeutic use , Formaldehyde , Hot Temperature , Hyperalgesia/metabolism , Indazoles/pharmacology , Male , Mice , Modafinil , NG-Nitroarginine Methyl Ester/pharmacology , Naloxone/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/metabolism , Pain/etiology , Pain/metabolism
7.
J Basic Clin Physiol Pharmacol ; 25(2): 211-5, 2014 May 01.
Article in English | MEDLINE | ID: mdl-24129104

ABSTRACT

BACKGROUND: Murraya koenigii (Rutaceae) (curry patta: Hindi) of the family Rutaceae is used in the traditional Indian system of medicine for its immunomodulatory properties. The essential oil of the leaves of M. koenigii possesses antimicrobial, antifungal, and pesticidal activities and is used for the treatment of amebiasis, diabetes, and hepatitis. The present study was performed to evaluate the effect of M. koenigii on humoral and cell-mediated immune responses in rats. METHODS: Aqueous extract of M. koenigii leaves was administered orally in a dose of 350 mg/kg. Cell-mediated immunity was assessed by measuring foot pad thickness following sensitization by injection of keyhole limpet hemocyanin and subsequent challenge by the same. Humoral immunity was assessed by measurement of hemagglutination titer to sheep red blood cells (SRBCs). RESULTS: In the humoral immune response, the administration of M. koenigii [350 mg/kg per os (p.o.)] from day 1 to day 7 after sensitization with SRBC on day 0 caused a significant increase in the primary anti-SRBC titer. However, the secondary immune response was decreased significantly (p<0.05) as shown by a decrease in secondary anti-SRBC titer measured on day 11 following a booster dose of antigen on day 8. In the delayed-type hypersensitivity test, M. koenigii (350 mg/kg, p.o.), when administered for 14 days, produced a significant (p<0.05) decrease in foot pad thickness when compared with the control group. CONCLUSIONS: Thus, these results suggest that oral administration of M. koenigii augments primary humoral immune response and decreases cell-mediated immunity.


Subject(s)
Hypersensitivity, Delayed/prevention & control , Immunity, Cellular/drug effects , Immunity, Humoral/drug effects , Immunologic Factors/pharmacology , Murraya/chemistry , Plant Extracts/pharmacology , Animals , Disease Models, Animal , Female , Hemagglutination Tests , Hypersensitivity, Delayed/immunology , Immunologic Factors/isolation & purification , Immunologic Factors/therapeutic use , Male , Plant Extracts/isolation & purification , Plant Extracts/therapeutic use , Plant Leaves/chemistry , Rats, Wistar
8.
Fundam Clin Pharmacol ; 27(2): 146-51, 2013 Apr.
Article in English | MEDLINE | ID: mdl-21790778

ABSTRACT

Melatonin is an important modulator of nervous system functioning and important neural antioxidant. Organophosphate pesticides like phosphamidon (PHOS) have been shown to adversely affect memory and induce oxidative stress on both acute and chronic exposure. This study was designed to explore the modulation of the effects of PHOS on cognitive function by melatonin (MEL). Cognitive function was assessed using step-down latency (SDL) on a passive avoidance apparatus and transfer latency (TL) on an elevated plus maze. Oxidative stress was assessed by examining the levels of malondialdehyde (MDA) and nonprotein thiols (NP-SH) in isolated homogenized whole brain samples. The results showed a significant reduction in SDL and prolongation of TL in the PHOS (1.74 mg/kg/day; p.o.)-treated group at weeks 6 and 8 as compared to the control group. Two-week treatment with MEL (5 mg/kg/day; i.p.) antagonized the effect of PHOS on SDL as well as TL. PHOS alone produced a significant increase in the brain MDA levels and decrease in the brain NP-SH levels. Treatment with MEL attenuated the effect of PHOS on oxidative stress. Together the results showed that MEL attenuated the cognitive dysfunction and decreased oxidative stress induced by PHOS in the brain.


Subject(s)
Cognition Disorders/drug therapy , Cognition/drug effects , Melatonin/pharmacology , Oxidative Stress/drug effects , Phosphamidon/toxicity , Animals , Brain/drug effects , Brain/metabolism , Cognition Disorders/chemically induced , Cognition Disorders/metabolism , Drug Interactions , Male , Malondialdehyde/metabolism , Random Allocation , Rats , Rats, Wistar , Sulfhydryl Compounds/metabolism
9.
Pharmacol Rep ; 64(2): 438-44, 2012.
Article in English | MEDLINE | ID: mdl-22661196

ABSTRACT

BACKGROUND: Resveratrol (3,4',5-trihydroxystilbene) is a naturally occurring compound found in grapes, wine, peanuts and cranberries. Recently, in vitro and cell culture studies have reported beneficial effects of resveratrol in the neurodegenerative process in Alzheimer's disease (AD). However, in vivo effect of resveratrol in models of learning and memory is not yet evaluated. The present study was performed to examine the effect of resveratrol on cognitive impairment induced by scopolamine, a muscarinic antagonist, in mice. METHODS: Scopolamine was administered in a dose of 1 mg/kg intraperitoneally (ip). Cognitive functions were assessed using transfer latency (TL) on elevated plus maze, step-down latency (SDL) on a passive avoidance apparatus and escape latency (EL) in Morris water maze test. RESULTS: Scopolamine produced significant prolongation of TL, reduction in SDL as well as EL showing cognitive impairment in mice. Pre-treatment with resveratrol (10 mg/kg and 20 mg/kg, ip) for 21 days showed no difference in TL, SDL and EL. CONCLUSION: Resveratrol treatment does not reverse scopolamine-induced deficit in cognitive functions in mice.


Subject(s)
Behavior, Animal/drug effects , Cognition Disorders/prevention & control , Memory Disorders/prevention & control , Neuroprotective Agents/therapeutic use , Stilbenes/therapeutic use , Animals , Avoidance Learning/drug effects , Cognition Disorders/chemically induced , Cognition Disorders/physiopathology , Injections, Intraperitoneal , Maze Learning/drug effects , Memory Disorders/chemically induced , Memory Disorders/physiopathology , Mice , Motor Activity/drug effects , Muscarinic Antagonists , Neuroprotective Agents/administration & dosage , Reaction Time/drug effects , Resveratrol , Scopolamine , Stilbenes/administration & dosage , Treatment Outcome
10.
Hum Exp Toxicol ; 30(10): 1626-34, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21257640

ABSTRACT

Progesterone (a neurosteroid) is an important modulator of the nervous system functioning. Organophosphorus pesticides like phosphamidon have been shown to adversely affect memory and induce oxidative stress on both acute and chronic exposure. The present study was therefore designed to investigate the effects of progesterone (PROG) on phosphamidon-induced modulation of cognitive function and oxidative stress in rats. Cognitive function was assessed using step-down latency (SDL) on a passive avoidance apparatus and transfer latency (TL) on an elevated plus maze. Oxidative stress was assessed by examining the levels of thiobarbituric acid reactive species (TBARS) and non-protein thiols (NP-SH) in isolated homogenized whole brain samples. The results showed a significant reduction in SDL and prolongation of TL in the phosphamidon (1.74 mg/kg/d; p.o.) treated group at weeks 6 and 8 as compared to the control group. Two weeks treatment with PROG (15 mg/kg/d; i.p.) antagonized the effect of phosphamidon on SDL as well as TL. Phosphamidon alone produced a significant increase in the brain TBARS levels and decrease in the brain NP-SH levels. Treatment with PROG (15 mg/kg/d; i.p.) attenuated the effect of phosphamidon on oxidative stress. Together, the results showed that progesterone attenuated the cognitive dysfunction and increased oxidative stress induced by phosphamidon in the brain.


Subject(s)
Insecticides/toxicity , Memory/drug effects , Oxidative Stress/drug effects , Phosphamidon/toxicity , Progesterone/pharmacology , Progestins/pharmacology , Animals , Avoidance Learning , Brain/drug effects , Brain/metabolism , Cognition Disorders/chemically induced , Cognition Disorders/drug therapy , Cognition Disorders/metabolism , Male , Maze Learning , Rats , Rats, Wistar , Sulfhydryl Compounds/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
11.
Can J Physiol Pharmacol ; 86(1-2): 64-9, 2008.
Article in English | MEDLINE | ID: mdl-18418448

ABSTRACT

Cocaine is a popular drug of abuse and despite impressive advances in the understanding of its physiological, pharmacological, and toxic effects, its mechanism of immunosuppression at the cellular level is not well understood. In this paper we report the role of effector molecules like superoxide and nitric oxide in the antibacterial function of macrophages exposed to acute and chronic doses of cocaine in vivo. Bacterial killing by acute cocaine-exposed macrophages (ACE-Mphis) increased significantly, with a concomitant rise in respiratory burst and generation of superoxide and nitric oxide, compared with control macrophages. In contrast, chronic cocaine-exposed macrophages (CCE-Mphis) exhibited limited antimicrobial activity, which correlated closely with diminished respiratory burst and reduced production of superoxide and nitric oxide. Further, a killing assay was carried out in the presence of N(G)-methyl-L-arginine acetate, an inhibitor of iNOS, to evaluate the role of nitric oxide in the killing process. The results obtained indicate that while about 30% killing of input bacteria by control and ACE-Mphis was attributable to NO-mediated killing, only about 6% killing from NO was found with CCE-Mphis. The findings indicate that acute exposure to cocaine possibly caused upregulation of enzymes responsible for the generation of ROI (reactive oxygen intermediates) and RNI (reactive nitrogen intermediates), leading to enhanced antimicrobial function. On the other hand, chronic exposure to cocaine impaired the oxygen-dependent microbicidal capacity of macrophages, possibly through impaired expression of enzymes responsible for ROI and RNI formation. Proinflammatory cytokines may play a key role in cocaine-mediated immunosuppression, since exposure of macrophages to cocaine impairs the ability of the cells to produce these cytokines.


Subject(s)
Cocaine/pharmacology , Macrophages/drug effects , Macrophages/immunology , Nitric Oxide/physiology , Superoxides/metabolism , Animals , Cytokines/physiology , Male , Mice , Mice, Inbred BALB C , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/metabolism , Respiratory Burst/drug effects , Staphylococcus aureus/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...